Instead of charging doctors for its valuable productivity tools, Doximity offers them for free to maximize user engagement. This creates a highly concentrated, valuable audience of physicians, which is then monetized through targeted advertising from pharmaceutical companies, its primary revenue source.

To effectively serve SMBs, B2B marketers must evolve their approach from collaboration ('do it with them') to automation ('do it for them'). SMB owners are not marketers and lack the time and staff to manage complex tools. The most valuable service is one that simplifies complexity and leverages technology to execute marketing tasks on their behalf, empowering them to achieve more with minimal direct involvement.

Fal treats every new model launch on its platform as a full-fledged marketing event. Rather than just a technical update, each release becomes an opportunity to co-market with research labs, create social buzz, and provide sales with a fresh reason to engage prospects. This strategy turns the rapid pace of AI innovation into a predictable and repeatable growth engine.

As AI and no-code tools make software easier to build, technological advantage is no longer a defensible moat. The most successful companies now win through unique distribution advantages, such as founder-led content or deep community building. Go-to-market strategy has surpassed product as the key differentiator.

While digital advertising constitutes 75% of spend in the general economy, it's only about half that in healthcare. This lag, driven by an entrenched reliance on in-person sales reps, creates a long-term secular tailwind for platforms like Doximity as the industry inevitably shifts its marketing budget online.

Doximity's product development is 'unapologetically' focused on increasing doctor productivity and saving them time. This user-centric approach builds deep engagement and trust, creating the highly valuable physician audience that forms the foundation of its advertising-based business model.

Doximity integrates multiple workflow tools like telehealth and e-signatures. While specialized competitors might offer better individual products, Doximity wins by providing a convenient, all-in-one platform that doctors are already engaged with daily, creating a powerful defensive moat.

Don't expect the parent company's sales force to sell your nascent product. Their focus on core business means they will ignore emerging tech. An internal incubator must have its own dedicated go-to-market team to find new personas and develop sales plays before a handoff.

An executive order mandated lengthy risk disclosures in pharmaceutical TV ads, reducing their effectiveness and ROI. This regulatory change made traditional consumer advertising less attractive, accelerating the shift of billions in pharma marketing spend toward more efficient digital channels like Doximity.